Status:

RECRUITING

Inari VISION Registry

Lead Sponsor:

Inari Medical

Conditions:

Pulmonary Embolism

Eligibility:

All Genders

18+ years

Brief Summary

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Eligibility Criteria

Inclusion

  • Willing and able to provide informed consent per institution and geographical requirements
  • Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
  • Currently within enrollment window relative to their procedure
  • Age ≥ 18 years

Exclusion

  • Is or will be inaccessible for registry follow-up
  • Meets exclusion criteria required by local requirements
  • Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
  • Is pregnant or breastfeeding at the time of enrollment

Key Trial Info

Start Date :

March 7 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2029

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06600542

Start Date

March 7 2025

End Date

December 31 2029

Last Update

December 3 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Santa Marta

Lisbon, Portugal

2

Southmead Hospital Bristol

Bristol, United Kingdom

3

Queen Elizabeth University Hospital

Glasgow, United Kingdom

4

Northwick Park Hospital

London, United Kingdom